136 related articles for article (PubMed ID: 33638914)
1. Chloracne: a case series on cutaneous expression of CYP1A1 as diagnostic biomarker.
Chessa MA; La Placa M; Patrizi A; Virdi A; Misciali C; Fedrizzi G; Filippi F; Saurat JH; Sorg O; Fontao F; Kaya G; Neri I
Clin Exp Dermatol; 2021 Jul; 46(5):896-900. PubMed ID: 33638914
[TBL] [Abstract][Full Text] [Related]
2. Aryl Hydrocarbon Receptor Activation in Acne Vulgaris Skin: A Case Series from the Region of Naples, Italy.
Fabbrocini G; Kaya G; Caseiro Silverio P; De Vita V; Kaya A; Fontao F; Sorg O; Saurat JH
Dermatology; 2015; 231(4):334-8. PubMed ID: 26440531
[TBL] [Abstract][Full Text] [Related]
3. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
4. RASopathic comedone-like or cystic lesions induced by vemurafenib: a model of skin lesions similar but not identical to those induced by dioxins MADISH.
Kaya G; Saxer-Sekulic N; Kaya A; Sorg O; Boespflug A; Thomas L; Saurat JH
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1368-1372. PubMed ID: 29575357
[TBL] [Abstract][Full Text] [Related]
5. Expression of AhR, CYP1A1, GSTA1, c-fos and TGF-alpha in skin lesions from dioxin-exposed humans with chloracne.
Tang NJ; Liu J; Coenraads PJ; Dong L; Zhao LJ; Ma SW; Chen X; Zhang CM; Ma XM; Wei WG; Zhang P; Bai ZP
Toxicol Lett; 2008 Apr; 177(3):182-7. PubMed ID: 18329192
[TBL] [Abstract][Full Text] [Related]
6. Dioxin-induced chloracne--reconstructing the cellular and molecular mechanisms of a classic environmental disease.
Panteleyev AA; Bickers DR
Exp Dermatol; 2006 Sep; 15(9):705-30. PubMed ID: 16881967
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
van Duursen MB; Sanderson JT; van den Berg M
Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
[TBL] [Abstract][Full Text] [Related]
8. Repression of aryl hydrocarbon receptor transcriptional activity by epidermal growth factor.
Hankinson O
Mol Interv; 2009 Jun; 9(3):116-8. PubMed ID: 19592671
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
[TBL] [Abstract][Full Text] [Related]
10. Chloracne, a misnomer and its implications.
Saurat JH; Sorg O
Dermatology; 2010 Aug; 221(1):23-6. PubMed ID: 20431274
[No Abstract] [Full Text] [Related]
11. TCDD-induced activation of aryl hydrocarbon receptor regulates the skin stem cell population.
Mandavia C
Med Hypotheses; 2015 Mar; 84(3):204-8. PubMed ID: 25618441
[TBL] [Abstract][Full Text] [Related]
12. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
[TBL] [Abstract][Full Text] [Related]
13. AhR signalling and dioxin toxicity.
Sorg O
Toxicol Lett; 2014 Oct; 230(2):225-33. PubMed ID: 24239782
[TBL] [Abstract][Full Text] [Related]
14. Toward elucidation of dioxin-mediated chloracne and Ah receptor functions.
Bock KW
Biochem Pharmacol; 2016 Jul; 112():1-5. PubMed ID: 26801687
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins.
Samer CF; Gloor Y; Rollason V; Guessous I; Doffey-Lazeyras F; Saurat JH; Sorg O; Desmeules J; Daali Y
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):296-303. PubMed ID: 31608602
[TBL] [Abstract][Full Text] [Related]
16. Chloracne: still cause for concern.
Passarini B; Infusino SD; Kasapi E
Dermatology; 2010 Aug; 221(1):63-70. PubMed ID: 20516651
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of chlorinated, brominated and mixed halogenated dioxins, furans and biphenyls as potent and as partial agonists of the Aryl hydrocarbon receptor.
Wall RJ; Fernandes A; Rose M; Bell DR; Mellor IR
Environ Int; 2015 Mar; 76():49-56. PubMed ID: 25540854
[TBL] [Abstract][Full Text] [Related]
18. Health status and plasma dioxin levels in chloracne cases 20 years after the Seveso, Italy accident.
Baccarelli A; Pesatori AC; Consonni D; Mocarelli P; Patterson DG; Caporaso NE; Bertazzi PA; Landi MT
Br J Dermatol; 2005 Mar; 152(3):459-65. PubMed ID: 15787814
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects.
McHale CM; Zhang L; Hubbard AE; Zhao X; Baccarelli A; Pesatori AC; Smith MT; Landi MT
Toxicology; 2007 Jan; 229(1-2):101-13. PubMed ID: 17101203
[TBL] [Abstract][Full Text] [Related]
20. Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands.
Furue M; Tsuji G
Int J Environ Res Public Health; 2019 Dec; 16(23):. PubMed ID: 31816860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
